Steve Brine MP

for Winchester & Chandler's Ford

14 JAN 2015

Local MP backs Duchenne treatment campaign

Winchester & Chandler's Ford MP Steve Brine has joined the fight for urgent access to a new rare disease treatment.

The campaign calls on NHS England to end delays to a breakthrough treatment which will allow some boys affected by a devastating muscle-wasting condition to stay on their feet for longer.

On Wednesday 14th January, Steve Brine joined fellow MPs and families as they were calling for fast access to a new pioneering drug for Duchenne muscular dystrophy. The condition causes irreversible muscle damage, with many boys needing a wheelchair by the time they are eight or nine years old. Problems with heart and lung muscles mean that few with the condition currently live to see their 30th birthday.

Translarna, the first drug of its kind in the UK, will allow some boys living with Duchenne muscular dystrophy, to stay on their feet for longer. Translarna has been designed for 10-15 percent of the 2,500 children and adults in the UK who have Duchenne muscular dystrophy caused by a 'nonsense' or 'stop' mutation. Countries including Spain, Germany, Italy and Denmark already have access to Translarna, but NHS administrative issues have led to agonising delays for families in the UK.

To be eligible for the treatment, Translarna, these boys must still be able to walk. Each day this treatment is delayed results in a greater risk that they could miss out on the drug entirely.

Steve Brine MP said: "A bureaucratic internal debate is currently preventing licensing of the drug Translarna, which can give these boys precious extra time on their feet.

"NHS England urgently needs to come up with a short-term solution as families affected by Duchenne muscular dystrophy do not have a single day to spare as their sons get weaker each day."

Robert Meadowcroft, Chief Executive of the Muscular Dystrophy Campaign, said:

"We greatly appreciate Steve Brine's support on this issue. Translarna is a long-awaited breakthrough. We must see an end to the delays in this drug reaching children who desperately need it.

"NHS administrative delays cannot lead to a situation in which even one child becomes ineligible for a drug that could have made a profound difference to their life, or even their future. We and families affected by Duchenne muscular dystrophy will be demanding action on Wednesday, for the many children who cannot afford to wait."

Back to all posts

Written Answers — Department of Health: General Practitioners: Kingston upon Hull West and Hessle (18 Sep 2017)
Steve Brine: NHS England is not aware of any practices having closed in this period, although there have been two mergers involving one or more practices in Hull West.

Written Answers — Department of Health: General Practitioners (18 Sep 2017)
Steve Brine: NHS England does not currently hold information on the number of patients who did not attend or dropped out of general practitioner (GP) appointments on either a local or national level. NHS England has directed NHS Digital to gather this information as part of a new national collection of GP workload information. This collection will begin shortly. Within the Kingston upon Hull West and...

Written Answers — Department of Health: NHS: Reorganisation (18 Sep 2017)
Steve Brine: Individual organisations that constitute each of the 44 Sustainability and Transformation Partnerships (STPs) are accountable to local communities for activities of each STP. Each is working to its own, locally appropriate timetable but many have already carried out extensive engagement with the public. When there are proposals to substantially change services, National Health Service and...

Contact Steve Brine in Westminster

Call your MP in his Commons office on 0207 219 7189 or email

Early Day Motions (EDMs)

Steve Brine does not sign EDMs - click here to read why.


Sign up to e-newsletter

Sign up for email updates:

First name: *

Last name: *

Email: *

Postcode: *